A brief look at the evaluation of the development and effectiveness of cytotoxic chemotherapy in advanced non-small-cell lung cancer

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridTanriverdi, Ozgur/0000-0002-0598-7284;
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidTanriverdi, Ozgur/M-2172-2015
dc.authorwosidKocak, Zafer/AEG-7828-2022
dc.contributor.authorUzunoglu, Sernaz
dc.contributor.authorKaragol, Hakan
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorCicin, Irfan
dc.contributor.authorCaloglu, Murat
dc.contributor.authorKocak, Zafer
dc.date.accessioned2024-06-12T11:09:20Z
dc.date.available2024-06-12T11:09:20Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstractSystemic chemotherapy for patients with advanced-stage non-small-cell lung cancer prolongs survival and palliates symptoms, when compared with the best supportive care alone. However, the results of standard cytotoxic regimens are not yet satisfactory. As the effectiveness in the treatment of refractory disease is low, it still remains critical to better understand and develop new treatment options for refractory disease. Within the second-line therapeutic approaches, there are new chemotherapeutic schemes as well as molecular-targeted treatment options that block the epidermal growth factor receptor or angiogenesis. Future research efforts should focus on identifying prognostic and predictive markers of benefit not only for the standard cytotoxic agents, but also for the new target-driven agents currently.en_US
dc.identifier.endpage85en_US
dc.identifier.issn1300-7467
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-78649833902en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage77en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22778
dc.identifier.volume25en_US
dc.identifier.wosWOS:000439263900006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherKare Publen_US
dc.relation.ispartofTurk Onkoloji Dergisi-Turkish Journal Of Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNon-Small-Cell Lung Canceren_US
dc.subjectSystemic Chemotherapyen_US
dc.subjectNew Generation Agentsen_US
dc.titleA brief look at the evaluation of the development and effectiveness of cytotoxic chemotherapy in advanced non-small-cell lung canceren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu